AstraZeneca's Farxiga granted fast track status for heart failure treatment

AstraZeneca Plc said on Monday the U.S. Food and Drug Administration (FDA) had granted fast track designation for the development of its diabetes drug Farxiga to reduce the risk of deadly heart attacks in some patients.

from Reuters: Health News https://ift.tt/2V0OZAO
via IFTTT